Enjoy these exclusive and compelling interviews from researchers around the world studying Crohn’s disease, mycobacteria and chronic immune disease.
Interviews with Dr. Ira Shafran, Dr. William Chamberlin, Dr. Robert Greenstein and John Aitken included.
Coronavirus, IBD, research updates & more! See what’s going on behind the scenes at Human Para and what we have planned for 2020.
Human Paratuberculosis Foundation is dedicated to providing the most up-to-date information in our field to assist patients around the world in making informed decisions about their treatment. We are grateful for the support of this community and look forward to taking this journey together. Read all the latest news and research about mycobacteria, particularly Mycobacterium avium subsp. paratuberculosis (MAP), and the treatment of Crohn’s and immune disease with AMAT and other innovative therapies. Enjoy!
March 24, 2020 is the 138th anniversary of Dr. Robert Koch’s famous meeting at the Berlin Physiological Society where he presented his findings on tuberculosis to a stunned audience. Researcher John Aitken (Otakaro Pathways, New Zealand) provides fresh insight into this historic event, and why it remains relevant in our fight against Crohn’s and MAP today.
After 3 years as a 501(c)(3) nonprofit, we are proud to report that 93.2% of our spending in 2019 was on innovative human MAP research projects! We continue to have very low overhead expenses due to our amazing volunteer team and the efforts of our researchers. See this 3 year pie chart for more detail on how your donations are put to work.
Human Paratuberculosis Foundation is dedicated to providing the most up-to-date information in our field to assist patients around the world in making informed decisions about their treatment. We are grateful for the support of this community and look forward to taking this journey together. Read all the latest news and research about mycobacteria, particularly Mycobacterium avium subsp. paratuberculosis (MAP), and the treatment of Crohn’s and immune disease with AMAT and other innovative therapies. Enjoy!